Browsing by Author Surapon Wiangnon

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
1-Jan-2019Childhood cancer incidence and survival in Thailand: A comprehensive population-based registry analysis, 1990–2011Serena S. Bidwell; Catherine C. Peterson; Kathryn Demanelis; Katie R. Zarins; Rafael Meza; Hutcha Sriplung; Surapon Wiangnon; Thirachit Chotsampancharoen; Imjai Chitapanarux; Donsuk Pongnikorn; Karnchana Daoprasert; Krittika Suwanrungruang; Wasan Chansaard; Laura S. Rozek
1-Jan-2018Childhood cancer incidence and survival in Thailand: A comprehensive population-based registry analysis, 1990–2011Serena S. Bidwell; Catherine C. Peterson; Kathryn Demanelis; Katie Zarins; Rafael Meza; Hutcha Sriplung; Surapon Wiangnon; Thirachit Chotsampancharoen; Imjai Chitapanarux; Donsuk Pongnikorn; Karnchana Daoprasert; Krittika Suwanrungruang; Wasan Chansaard; Laura S. Rozek
1-Jan-2005Hospital-based epidemiologic survey of malignancies in children infected with human immunodeficiency virus in ThailandChitsanu Pancharoen; Issarang Nuchprayoon; Usa Thisyakorn; Kulkanya Chokephaibulkit; Gavivann Veerakul; Warunee Punpanich; Somjai Kanjanapongkul; Jutarat Mekmullica; Jurai Wongsawat; Piyaporn Bowonkiratikachorn; Suchat Hongsiriwon; Pattra Thanarattanakorn; Pope Kosalaraksa; Surapon Wiangnon; Anucha Saerejittima; Somsri Kochavate
1-Jan-2015Incidences, trends and long term outcomes of retinoblastoma in three cancer registries, ThailandPiyathida Wongmas; Arunee Jetsrisuparb; Patcharee Komvilaisak; Krittika Suwanrungruang; Worawut Choeyprasert; Hutcha Sriplung; Surapon Wiangnon
1-Jun-2010Late effects in survivors of childhood acute lymphoblastic leukemia: A study from Thai Pediatric Oncology GroupSamart Pakakasama; Gavivann Veerakul; Darin Sosothikul; Su On Chainansamit; Vichai Laosombat; Pattra Thanarattanakorn; Rachata Lumkul; Surapon Wiangnon; Somporn Wangruangsathit; Nattee Narkbunnam; Somjai Kanjanapongkul
1-Sep-2022Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology GroupKunanya Suwannaying; Chalinee Monsereenusorn; Piya Rujkijyanont; Piti Techavichit; Kamon Phuakpet; Pongpak Pongphitcha; Su on Chainansamit; Thirachit Chotsampancharoen; Angkana Winaichatsak; Chanchai Traivaree; Lalita Sathitsamitphong; Somjai Kanjanapongkul; Patcharee Komvilaisak; Kleebsabai Sanpakit; Apichat Photia; Panya Seksarn; Surapon Wiangnon; Suradej Hongeng
1-Sep-2022Treatment outcomes of high-dose chemotherapy plus stem cell rescue in high-risk neuroblastoma patients in ThailandKunanya Suwannaying; Piti Techavichit; Patcharee Komvilaisak; Napat Laoaroon; Nattee Narkbunnam; Kleebsabai Sanpakit; Kanhatai Chiengthong; Thirachit Chotsampancharoen; Lalita Sathitsamitphong; Chalongpon Santong; Panya Seksarn; Suradej Hongeng; Surapon Wiangnon